NCT01244841

Brief Summary

In patients with ST elevation myocardial infarction (STEMI)treated with primary percutaneous coronary intervention (PPCI) a subset with low risk for late complications can be identified. Early discharge (\<72h) of these patients can compromise initiation of prophylaxis, information and other investigations. The researchers want to investigate prospectively whether early discharge compared to regular care have comparable patient centered outcomes at 30 days follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 12, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 19, 2010

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

May 9, 2013

Status Verified

May 1, 2013

Enrollment Period

2.2 years

First QC Date

October 12, 2010

Last Update Submit

May 7, 2013

Conditions

Keywords

ST elevation acute myocardial infarctionPrimary percutaneous coronary interventionDischargeHealth statusQuality of care

Outcome Measures

Primary Outcomes (1)

  • Evaluate whether the health status after early discharge compared to standard care is comparable in low-risk primary PCI patients.

    This is an equivalence study comparing health related quality of life(HRQOL) and quality-of-care satisfaction between the 3 days stay and standard regimen groups at 30 days after AMI. The scores of the SF-36, Seattle Angina Questionaire and Hospital Anxiety \& Depression Scale for patients in both study groups will be compared. The forms will be filled out by the patients at baseline and at 30 days follow-up.

    1 month

Secondary Outcomes (2)

  • Comparison between the study groups of readmission rates within 1 month.

    30 days

  • Comparison between the study groups of compliance with, and target dosing of medical therapy.

    1 month

Study Arms (2)

Standard care

NO INTERVENTION

Randomised to standard post MI care and length of hospital stay decided by treating physician.

Early discharge

ACTIVE COMPARATOR

Randomised patient where all post MI investigations, treatment, follow-up plans and information will be performed within 3 days, and the patients are thereafter discharged.

Procedure: fast post MI care

Interventions

All post MI investigations, treatment, start of medication, information are performed within 3 days after admittance.

Early discharge

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ST elevation acute myocardial infarction
  • Undergoing primary PCI

You may not qualify if:

  • Zwolle low risk criteria score \>4
  • Re-infarction, post AMI ischemia.
  • Need for urgent repeat invasive procedures.
  • Non-cardiac complication (bleeding, stroke oa.) or concomitant diseases likely to increase length of hospital stay.
  • Early discharge impossible due to social, nursing or family reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stavanger University Hospital

Stavanger, Rogaland, 4068, Norway

Location

Study Officials

  • Tor Melberg, MD PhD

    Helse Stavanger HF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2010

First Posted

November 19, 2010

Study Start

September 1, 2010

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

May 9, 2013

Record last verified: 2013-05

Locations